Gosha Colquhoun

Dr. Gosha Colquhoun

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2021 in Archives of Public Health
Verified
Journal Article
Open access
PDF file
Gosha ColquhounGosha Colquhoun
Gosha Colquhoun
NRNicola Ring
Nicola Ring
CMCorrienne McCulloch
Corrienne McCulloch
DWDiane S. Willis
Diane S. Willis
BWBrian Williams
Brian Williams
KKKalliopi Kydonaki
Kalliopi Kydonaki
Background: Antimicrobial resistance poses a serious global public health threat. Hospital misuse of antibiotics has contributed to this problem and evidence-based interventions are urgently needed to change inappropriate prescribing practices. This paper reports the first theoretical stage of a longer-term project to improve antibiotic prescribing in hospitals through design of an effective behaviour-change intervention. Methods: Qualitative synthesis using meta-ethnography of primary studies reporting doctors’ views and experiences of antibiotic prescribing in hospitals for example, their barriers to appropriate prescribing. Twenty electronic databases were systematically searched over a 10-year period and potential studies screened against eligibility criteria. Included studies were quality-appraised. Original participant quotes and author interpretations were extracted and coded thematically into NVivo. All study processes were conducted by two reviewers working independently with findings discussed with the wider team and key stakeholders. Studies were related by findings into clusters and translated reciprocally and refutationally to develop a new line-of-argument synthesis and conceptual model. Findings are reported using eMERGe guidance. Results: Fifteen papers (13 studies) conducted between 2007 and 2017 reporting the experiences of 336 doctors of varying seniority working in acute hospitals across seven countries, were synthesised. Study findings related in four ways which collectively represented multiple challenges to appropriate antibiotic medical prescribing in hospitals: loss of ownership of prescribing decisions, tension between individual care and public health concerns, evidence-based practice versus bedside medicine, and diverse priorities between different clinical teams. The resulting new line-of-argument and conceptual model reflected how these challenges operated on both micro- and macro-level, highlighting key areas for improving current prescribing practice, such as creating feedback mechanisms, normalising input from other specialties and reducing variation in responsibility for antibiotic decisions. Conclusions: This first meta-ethnography of doctors` experiences of antibiotic prescribing in acute hospital settings has enabled development of a novel conceptual model enhancing understanding of appropriate antibiotic prescribing. That is, hospital antibiotic prescribing is a complex, context-dependent and dynamic process, entailing the balancing of many tensions. To change practice, comprehensive efforts are needed to manage failures in communication and information provision, promote distribution of responsibility for antibiotic decisions, and reduce fear of consequences from not prescribing. Trial registration: PROSPERO registration: CRD42017073740.

3 July 2024 in JAC-Antimicrobial Resistance
Verified
Journal Article
Open access
PDF file
Gosha ColquhounGosha Colquhoun
Gosha Colquhoun
JAJanyne Afseth
Janyne Afseth
RFRoss Fagan
Ross Fagan
FTFiona Thomson
Fiona Thomson
NRNicola Ring
Nicola Ring
Objectives: To further develop an understanding of laypeople’s (adult patients and public) beliefs and attitudes toward antimicrobial resistance (AMR) by developing a conceptual model derived from identifying and synthesizing primary qualitative research. Methods: A systematic search of 12 electronic databases, including CINAHL, MEDLINE, PsycINFO, PubMed and Web of Science to identify qualitative primary studies exploring patient and public understanding of AMR published between 2012 and 2022. Included studies were quality appraised and synthesized using Noblit and Hare’s meta-ethnographic approach and reported using eMERGe guidance. Results: Thirteen papers reporting 12 qualitative studies were synthesized. Studies reported data from 466 participants aged 18–90 years. Five themes were identified from these original studies: the responsible patient; when words become meaningless; patient–prescriber relationship; past experience drives antibiotic use; and reframing public perception. These themes supported the development of a conceptual model that illustrates the tension between two different assumptions, that is, how can antibiotics be used for the collective good whilst balancing the immediate needs of individual patients. Conclusions: Findings suggest that AMR is a distinct ethical issue and should not be viewed purely as a prescribing problem. The meta-ethnography-generated conceptual model illustrates many factors affecting the public’s perception of AMR. These include laypeople’s own knowledge, beliefs and attitudes around antibiotic use, the relationship with the healthcare provider and the wider context, including the overwhelming influence of the media and public health campaigns. Future research is needed to explore effective health messaging strategies to increase laypeople’s baseline awareness of AMR as a public threat.

28 February 2023 in Psychology & Health
Verified
Journal Article
Open access
Gosha ColquhounGosha Colquhoun
Gosha Colquhoun
NRNicola Ring
Nicola Ring
DWD. S. Willis
D. S. Willis
BWB. Williams
B. Williams
KKKalliopi Kydonaki
Kalliopi Kydonaki
To develop a theory-informed behaviour change intervention to promote appropriate hospital antibiotic use, guided by the Medical Research Council’s complex interventions framework.A phased approach...

20 November 2017 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
TCThomas H. Craven
Thomas H. Craven
Gosha ColquhounGosha Colquhoun
Gosha Colquhoun
JMJodie McCoubrey
Jodie McCoubrey
OBOdette Brooks
Odette Brooks
EGEsther Grant
Esther Grant
TWTimothy S. Walsh
Timothy S. Walsh

5 March 2026 in International Journal of Social Robotics
Verified
Journal Article
Open access
ABAmani Al Bayrakdar
Amani Al Bayrakdar
Gosha ColquhounGosha Colquhoun
Gosha Colquhoun
MDMauro Dragone
Mauro Dragone
AMAlistair McConnell
Alistair McConnell
RPRuth Paterson
Ruth Paterson
Over 537 million adults live with diabetes, yet many lack sufficient support for effective self-management, resulting in suboptimal glycaemic levels and rising healthcare costs. Socially assistive robots (SARs) may fill this gap through offering real-time, personalised support. This study explored adults’ views on the design, usability, and acceptability of a SAR-based intervention. A three-phase exploratory co-design approach, guided by the Medical Research Council framework, involved 16 adults with type 1 and 2 diabetes in Scotland. Phase 1 involved forming a working group and conducting a scoping review. Phase 2 included two online focus groups to identify challenges, technology use, and desired SAR features; and two in-person workshops at the UK National Robotarium to assess SAR’s usability, acceptability, and integration into daily life. Phase 3 involved thematic analysis, translating user requirements, and planning future feasibility. Participants identified barriers including dietary adherence, insulin adjustments, and limited access to clinicians. Technologies like glucose monitors and insulin pumps were seen as burdensome, highlighting the need for personalised, on-demand support. In conceptualising a SAR, participants recommended interactive coaching features, such as real-time medication guidance, meal planning, emergency alerts, and data-sharing. Priorities included a user-friendly, inclusive design, strong data privacy, and integration with existing devices and care pathways. SARs offer a feasible approach to personalised self-management, with user-driven features like tailored coaching, accessible design, and healthcare connectivity improving glycaemic levels and well-being. These findings inform prototyping and evaluation of a new SAR intervention for diabetes management.

26 March 2026 in BMJ Open
Verified
Journal Article
Open access
PMPhil Mawson
Phil Mawson
MMMiranda Morton
Miranda Morton
ZWZoe Walmsley
Zoe Walmsley
RWRebecca Wafer
Rebecca Wafer
HHHelen C Hancock
Helen C Hancock
THTom Hellyer
Tom Hellyer
Introduction: Sepsis is a life-threatening syndrome resulting from a dysregulated immune response to an infection. Patients with sepsis can become critically ill and require advanced organ support in a hospital critical care setting. Antibiotics are lifesaving in sepsis, but overuse is associated with harm and promotes antimicrobial resistance, a rising global challenge making antibiotic treatment less effective. The prevalence of antibiotic use is very high in patients admitted to critical care. Research indicates that shorter courses of antibiotics are as effective as longer durations in the treatment of certain infections, but uncertainty remains for patients with sepsis. The aim of SHORTER is to investigate whether treating critically ill patients with suspected or confirmed sepsis with a fixed 5-day, short course of antibiotics is clinically and cost-effective compared with standard of care. Methods and analysis: SHORTER is a pragmatic, multicentre, randomised controlled trial. 2244 adults treated with antibiotics for suspected or confirmed sepsis in a critical care setting will be recruited from 50 UK National Health Service hospitals. Participants will be randomised to either a fixed 5-day index course of antibiotics (intervention) or standard of care duration antibiotics (control). The coprimary outcomes are 28-day mortality (non-inferiority) and antibiotic treatment days (superiority). Secondary outcomes will assess the effect of short-duration antibiotic therapy on 90-day mortality, hospital readmissions, further infection rates and health economic impacts. A process evaluation will be embedded in the trial. Ethics and dissemination: Favourable ethical opinion has been received from the Wales Research Ethics Committee 4 (Ref: 23/WA/0197) and Scotland A REC (Ref: 24/SS/0013). Results will be publicly disseminated via Patient Public Involvement and Engagement representatives, charities and media, and to the clinical community via professional societies, peer-reviewed publications and conference presentations. Trial registration number: ISRCTN40090372 .